An Illinois law that targets “price gouging” for generic drugs is the target of a lawsuit filed by the trade group representing America’s generics and biosimilar manufacturers who claim the law is a constitutional overreach that would have Illinois regulating transactions outside that state.
Source: Drug Industry Daily